LAURA MACKE: Open Payments
NPI 1174194369 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,636 in 84 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $391 · 2025 $1,636
Food & beverage: $1,617Travel & lodging: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $286 |
| Corium, LLC | 9 | $250 |
| Teva Pharmaceuticals USA, Inc. | 8 | $176 |
| Otsuka America Pharmaceutical, Inc. | 7 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $139 |
| Noven Therapeutics, LLC | 6 | $113 |
| Janssen Pharmaceuticals, Inc | 5 | $95 |
| Tris Pharma Inc | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $60 |
Products named: VRAYLAR, Azstarys, AUSTEDO XR, REXULTI, CAPLYTA, Xelstrym, Dyanavel XR, SPRAVATO.
Industry payments across TX — which companies pay providers there.
